CA2549333C - Treatment of ophthalmic conditions - Google Patents

Treatment of ophthalmic conditions Download PDF

Info

Publication number
CA2549333C
CA2549333C CA2549333A CA2549333A CA2549333C CA 2549333 C CA2549333 C CA 2549333C CA 2549333 A CA2549333 A CA 2549333A CA 2549333 A CA2549333 A CA 2549333A CA 2549333 C CA2549333 C CA 2549333C
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
cornea
patient
eye
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2549333A
Other languages
English (en)
French (fr)
Other versions
CA2549333A1 (en
Inventor
Alberto Osio Sancho
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osio Corp
Original Assignee
Osio Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osio Corp filed Critical Osio Corp
Publication of CA2549333A1 publication Critical patent/CA2549333A1/en
Application granted granted Critical
Publication of CA2549333C publication Critical patent/CA2549333C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04—Contact lenses for the eyes
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04—Contact lenses for the eyes
    • G02C7/047—Contact lens fitting; Contact lenses for orthokeratology; Contact lenses for specially shaped corneae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Optics & Photonics (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Eyeglasses (AREA)
  • Prostheses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Materials For Medical Uses (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
CA2549333A 2003-12-19 2004-12-17 Treatment of ophthalmic conditions Expired - Lifetime CA2549333C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
MX011987 2003-12-19
MXPA03011987A MXPA03011987A (es) 2003-12-19 2003-12-19 Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal.
PCT/US2004/042660 WO2005062818A2 (en) 2003-12-19 2004-12-17 Treatment of ophthalmic conditions

Publications (2)

Publication Number Publication Date
CA2549333A1 CA2549333A1 (en) 2005-07-14
CA2549333C true CA2549333C (en) 2014-08-05

Family

ID=34740239

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2549333A Expired - Lifetime CA2549333C (en) 2003-12-19 2004-12-17 Treatment of ophthalmic conditions

Country Status (16)

Country Link
US (6) US8475831B2 (de)
EP (1) EP1706094B1 (de)
JP (4) JP2007514760A (de)
KR (1) KR20070012329A (de)
CN (1) CN100591354C (de)
AU (1) AU2004308326B2 (de)
BR (1) BRPI0417785A (de)
CA (1) CA2549333C (de)
CR (1) CR8453A (de)
EC (1) ECSP066657A (de)
EG (1) EG24420A (de)
IL (1) IL176397A (de)
MX (1) MXPA03011987A (de)
RU (1) RU2006126077A (de)
WO (1) WO2005062818A2 (de)
ZA (1) ZA200605950B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03011987A (es) 2003-12-19 2005-06-23 Osio Sancho Alberto Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal.
JP4653437B2 (ja) * 2004-08-04 2011-03-16 株式会社ニデック オルソケラトロジー処方支援システム
US8409177B1 (en) 2005-10-13 2013-04-02 Shui T. Lai Intrastromal refractive surgery by inducing shape change of the cornea
US7726811B2 (en) 2006-02-14 2010-06-01 Lai Shui T Subjective wavefront refraction using continuously adjustable wave plates of Zernike function
US7748844B2 (en) 2006-06-15 2010-07-06 Lai Shui T High visual acuity contact lenses
WO2008014330A2 (en) 2006-07-25 2008-01-31 Lai Shui T Method of making high precision optics having a wavefront profile
GB0724558D0 (en) * 2007-12-15 2008-01-30 Sharma Anant Optical correction
JP5748480B2 (ja) * 2007-12-17 2015-07-15 モー リサーチ アプリケーションズ エルティーディー 高浸透圧アイコンタクトレンズ
MX2011011793A (es) * 2009-05-04 2012-01-30 Coopervision Int Holding Co Lp Lentes oftalmicas y reduccion del error de acomodacion.
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
US20100298335A1 (en) * 2009-05-22 2010-11-25 Kaufman Herbert E Preparations and Methods for Ameliorating or Reducing Presbyopia
WO2011049642A1 (en) 2009-10-22 2011-04-28 Coopervision International Holding Company, Lp Contact lens sets and methods to prevent or slow progression of myopia or hyperopia
CA3049795A1 (en) 2011-09-20 2013-03-28 Juan Carlos Abad Compositions and methods for treating presbyopia, mild hyperopia, and irregular astigmatism
ES2994608T3 (en) * 2012-08-10 2025-01-27 Osio Corp D/B/A Yolia Health Contact lens use in the treatment of an ophthalmologic condition
KR101454646B1 (ko) * 2012-11-05 2014-10-27 (주)한국비엠아이 히알루로니다아제의 안정화 제제 및 이를 포함하는 액상제제
US11079613B2 (en) * 2013-03-05 2021-08-03 EyeYon Medical Ltd. Contact lens drug depot
CN107206003B (zh) * 2014-12-02 2021-10-26 艾维德洛公司 用于眼的交联治疗的系统、方法和组合物
MY186271A (en) 2015-03-05 2021-07-01 Auckland Uniservices Ltd Ophthalmic compositions and methods of use therefor
US9709822B2 (en) 2015-03-11 2017-07-18 Vance M. Thompson Orthokeratology lens with displaced shaping zone
EP3108874A1 (de) * 2015-06-26 2016-12-28 TRB Chemedica AG Pharmazeutische zubereitung zur anwendung am auge
MX2019001877A (es) 2016-08-19 2019-09-13 Orasis Pharmaceuticals Ltd Composiciones farmaceuticas oftalmicas y usos que se relacionan a las mismas.
HUE069999T2 (hu) * 2017-03-06 2025-04-28 Tsubota Lab Inc Kompozíció miópia megelõzésében vagy szuppressziójában történõ alkalmazásra
JP6969606B2 (ja) 2017-03-23 2021-11-24 ソニーグループ株式会社 検出機能付きプロジェクタ
CN110785149B (zh) * 2017-04-28 2022-10-04 华柏恩视觉研究中心有限公司 用于控制近视进展的系统、方法和装置
WO2019075263A2 (en) * 2017-10-11 2019-04-18 Illustris Pharmaceuticals, Inc. METHODS AND COMPOSITIONS WITH TOPICAL ADMINISTRATION
EP3735209A4 (de) 2018-01-05 2021-09-08 University of Utah Research Foundation Behandlung der progression von myopoie
WO2019167040A1 (en) * 2018-03-01 2019-09-06 Bar Ilan University System, method and material composition for use in correction of eye conditions
EP3861402A1 (de) * 2018-12-21 2021-08-11 Alcon Inc. Kante mit mehreren krümmungen für brillengläser
US20210000910A1 (en) 2019-07-03 2021-01-07 Jysk Skin Solutions Pte Ltd Topical compositions
US20220334409A1 (en) * 2019-09-25 2022-10-20 Nthalmic Holding Pty Ltd A contact lens solution for myopia management
CA3210975A1 (en) * 2021-02-22 2022-08-25 Tend Health, Inc. Stool sample collection and processing system
US12083204B2 (en) 2022-06-02 2024-09-10 L'oreal Topical composition for homeostatic delivery of nitric oxide and uses thereof
CN116919967B (zh) * 2023-02-02 2026-03-03 山东第一医科大学附属眼科研究所(山东省眼科研究所、山东第一医科大学附属青岛眼科医院) 亚叶酸钙在制备促角膜修复药物中的应用

Family Cites Families (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5413510B2 (de) 1973-08-28 1979-05-31
US3957049A (en) 1973-10-09 1976-05-18 Neefe Charles W Rechargeable drug delivery method
US4525043A (en) 1977-11-11 1985-06-25 Leonard Bronstein Contact lens
JPS6033474B2 (ja) 1978-05-11 1985-08-02 藤沢薬品工業株式会社 新規なヒアルロニダ−ゼｂｍｐ−８２３１およびその製造法
US4418991A (en) * 1979-09-24 1983-12-06 Breger Joseph L Presbyopic contact lens
US4484922A (en) 1981-06-25 1984-11-27 Rosenwald Peter L Occular device
US4571039A (en) 1983-04-15 1986-02-18 Stanley Poler Eye-medicating contact-lens construction
US4540417A (en) 1983-05-02 1985-09-10 Stanley Poler Eye-medicating haptic
US4601556A (en) 1983-10-26 1986-07-22 Siviglia Nick C Corneal contact lens for the eye of a patient with keratoconus disease and method of making the same
US5316926A (en) 1983-11-25 1994-05-31 Miles Inc. Method for the microbiological production of non-antigenic hyaluronic acid
GB8504025D0 (en) 1985-02-16 1985-03-20 Biopharm Ltd Hyaluronidase
US4592752A (en) 1985-08-02 1986-06-03 Neefe Charles W Non-optical corneal drug delivery
US4851513A (en) 1985-09-06 1989-07-25 Minnesota Mining And Manufacturing Company Viscoelastic collagen solution for opthalmic use and method of preparation
US4713446A (en) 1985-09-06 1987-12-15 Minnesota Mining And Manufacturing Company Viscoelastic collagen solution for ophthalmic use and method of preparation
US5484432A (en) 1985-09-27 1996-01-16 Laser Biotech, Inc. Collagen treatment apparatus
US4820016A (en) 1986-02-21 1989-04-11 American Telephone And Telegraph Company, At&T Bell Laboratories Waveguide-containing communications and sensing systems
SE456245B (sv) 1986-07-09 1988-09-19 Pharmacia Ab Enzympreparation innehallande krillhyaluronidas
US4759746A (en) 1987-05-14 1988-07-26 Straus Jeffrey G Retro-bulbar needle
US4969912A (en) 1988-02-18 1990-11-13 Kelman Charles D Human collagen processing and autoimplant use
US4881543A (en) 1988-06-28 1989-11-21 Massachusetts Institute Of Technology Combined microwave heating and surface cooling of the cornea
US5360611A (en) 1988-10-03 1994-11-01 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
NO164844C (no) 1988-10-24 1990-11-21 Norsk Hydro As Fremgangsmaate ved utvinning av enzymer fra krepsdyr.
EP0456724B1 (de) 1989-01-27 1995-05-03 Immunolytics, Inc. Zusammensetzung und verfahren für die behandlung gutartiger prostata-hypertrophie
US4897349A (en) 1989-04-28 1990-01-30 Medchem Products, Inc. Biosynthesis of hyaluronic acid
US4952045B1 (en) 1989-05-26 2000-08-08 Contex Inc Corneal contact lens and method for treating myopea
US5015577A (en) 1989-08-29 1991-05-14 Board Of Regents, The University Of Texas System DNA encoding hyaluronate synthase
US5201764A (en) 1990-02-28 1993-04-13 Autogenesis Technologies, Inc. Biologically compatible collagenous reaction product and articles useful as medical implants produced therefrom
ZA912770B (en) 1990-04-16 1992-01-29 Bethesda Eye Inst Enzymatic disinsertion of vitreous body
US5196027A (en) 1990-05-02 1993-03-23 Thompson Keith P Apparatus and process for application and adjustable reprofiling of synthetic lenticules for vision correction
EP0459148B1 (de) 1990-05-29 1996-01-03 Ocular Research Of Boston Inc. Zusammensetzung zur Behandlung von Dry Eye Erkrankungen
US5779696A (en) 1990-07-23 1998-07-14 Sunrise Technologies International, Inc. Method and apparatus for performing corneal reshaping to correct ocular refractive errors
US5163956A (en) 1990-11-06 1992-11-17 General Electric Company Methods and lenticules for modifying the cornea
US5144630A (en) 1991-07-29 1992-09-01 Jtt International, Inc. Multiwavelength solid state laser using frequency conversion techniques
US5270051A (en) * 1991-10-15 1993-12-14 Harris Donald H Enzyme-orthokeratology
EP1159941A3 (de) 1991-10-15 2003-09-17 Ista Pharmaceuticals, Inc. Zusammensetzung zur Verwendung in der Enzymkeratologie
US5788957A (en) 1991-10-15 1998-08-04 Advanced Corneal Systems, Inc. Enzyme-orthokeratology
US5465737A (en) 1992-07-15 1995-11-14 Schachar; Ronald A. Treatment of presbyopia and other eye disorders
US5354331A (en) 1992-07-15 1994-10-11 Schachar Ronald A Treatment of presbyopia and other eye disorders
US5492135A (en) 1992-09-09 1996-02-20 Devore; Dale P. Collagen modulators for use in photoablation excimer laser keratectomy
US5520679A (en) 1992-12-03 1996-05-28 Lasersight, Inc. Ophthalmic surgery method using non-contact scanning laser
US5593877A (en) 1993-03-11 1997-01-14 The Rockefeller University Nucleic acid and recombinant production of vespid venom hyaluronidase
US5496726A (en) 1993-04-16 1996-03-05 Lucky Limited Streptococcus zooepidemicus medium and process for preparing hyaluronic acid
US5894002A (en) 1993-12-13 1999-04-13 Ciba Vision Corporation Process and apparatus for the manufacture of a contact lens
JPH0867617A (ja) 1994-08-31 1996-03-12 Tsuneo Nanba 化粧料
WO1996011672A1 (en) 1994-10-13 1996-04-25 Wakamoto Pharmaceutical Co., Ltd. Lyophilized preparation providing reversibly thermogelling water-base medicinal composition
US5792103A (en) 1995-02-03 1998-08-11 Schwartz; Daniel M. Viscosurgical method and apparatus
US5518732A (en) 1995-02-14 1996-05-21 Chiron Vision, Inc. Bio-erodible ophthalmic shield
US5695509A (en) 1995-03-10 1997-12-09 El Hage; Sami G. Aspherical optical molds for continuous reshaping the cornea based on topographical analysis
US5747027A (en) 1995-04-07 1998-05-05 The Regents Of The University Of California BH55 hyaluronidase
US5866120A (en) 1995-11-22 1999-02-02 Advanced Corneal Systems, Inc. Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase
US6610292B2 (en) 1995-11-22 2003-08-26 Ista Pharmaceuticals, Inc. Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
US6099121A (en) 1996-06-07 2000-08-08 Bausch & Lomb Incorporated Contact lens design
US6010219A (en) 1996-06-28 2000-01-04 Contex, Inc. Fenestrated contact lens for treating myopia
US5815237A (en) 1996-07-01 1998-09-29 Bausch & Lomb Incorporated Contact lens and method for making the same
KR100514277B1 (ko) 1996-09-13 2005-09-13 유겐가이샤 사이센딴이가꾸겡꾸쇼 신경 영양 인자의 안과용 조성물, 시신경 기능 장애 치료제 및 시신경 기능 장애 치료 방법
US6123938A (en) 1996-10-17 2000-09-26 The Regents Of The University Of California Human urinary hyaluronidase
CA2276287C (en) 1997-01-06 2007-10-30 Klaus Trier Aps Screening method for compounds active in treating myopia and hypermetropia
US6037144A (en) 1997-01-29 2000-03-14 Staar Surgical Ag Method of preparing a biological material for use in ophthalmology
US5815327A (en) 1997-03-14 1998-09-29 Xerox Corporation Photolithographic method of fabricating fresnel lenses
WO1998052090A1 (en) 1997-05-16 1998-11-19 Corrective Vision, Inc. Improved contact lens
US5963297A (en) 1997-06-27 1999-10-05 Reim; Thomas Russell Orthokeratology contact lens and method therefor
US6161544A (en) 1998-01-28 2000-12-19 Keratoform, Inc. Methods for accelerated orthokeratology
AU2677299A (en) 1998-02-17 1999-08-30 Schepens Eye Research Institute, Inc., The Use of hyaluronidase to reduce viscoelastic related increases in intraocular pressure
JP2002506013A (ja) 1998-03-09 2002-02-26 イスタ ファーマシューティカルズ インコーポレイテッド 酵素角膜矯正術における角膜硬化剤の使用
US6595986B2 (en) 1998-10-15 2003-07-22 Stephen Almeida Multiple pulse photo-dermatological device
US6263879B1 (en) 1998-11-10 2001-07-24 J. T. Lin Treatment of presbyopia and other eye disorders using a scanning laser system
IL127209A0 (en) * 1998-11-23 1999-09-22 Bio Silk Ltd Composition and method for treatment of hypertrophic skin accumulations and their prevention
US6335006B1 (en) 1999-03-22 2002-01-01 Boston Innovative Optics, Inc. Methods of using agents that act on the epithelial sheet of a human eye
JP2002543143A (ja) 1999-04-29 2002-12-17 イスタ・ファーマスーティカルズ・インコーポレイテッド 角膜の瘢痕、混濁およびかすみを無くす生化学的方法
US6258082B1 (en) 1999-05-03 2001-07-10 J. T. Lin Refractive surgery and presbyopia correction using infrared and ultraviolet lasers
US6946440B1 (en) 1999-09-15 2005-09-20 Dewoolfson Bruce H Composition for stabilizing corneal tissue during or after orthokeratology lens wear
US6428785B1 (en) * 1999-10-28 2002-08-06 Immunolytics Inc. Method and composition for treating prostate cancer
US6426208B1 (en) 1999-11-12 2002-07-30 Harbor-Ucla Research And Education Institute Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
US6569661B1 (en) 1999-11-12 2003-05-27 Biomarin Pharmaceutical Inc. Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
US6585971B1 (en) 1999-11-12 2003-07-01 Harbor-Ucla Research And Education Institute Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof
RU2166785C1 (ru) 2000-03-17 2001-05-10 ЗАО "Диафарм" Очищающий раствор для контактных линз
US6886936B2 (en) 2000-07-28 2005-05-03 Ocular Sciences, Inc. Contact lenses with blended microchannels
US6652095B2 (en) 2000-11-17 2003-11-25 Hsiao-Ching Tung Orthokeratology and bi-focal contact lens
US6543897B1 (en) 2000-11-17 2003-04-08 Hsiao-Ching Tung Orthokeratology contact lens
US6902548B1 (en) 2001-03-19 2005-06-07 Ed Schuler Use of Streptomyces hyalurolyticus enzyme in ophthalmic treatments
JP2002350787A (ja) 2001-03-21 2002-12-04 Menicon Co Ltd コンタクトレンズ
US6745776B2 (en) 2001-04-10 2004-06-08 David B. Soll Methods for reducing postoperative intraocular pressure
US6875427B1 (en) 2001-10-09 2005-04-05 Tissue Adhesive Technologies, Inc. Light energized tissue adhesive
US6939364B1 (en) 2001-10-09 2005-09-06 Tissue Adhesive Technologies, Inc. Composite tissue adhesive
US6780840B1 (en) 2001-10-09 2004-08-24 Tissue Adhesive Technologies, Inc. Method for making a light energized tissue adhesive
US6773699B1 (en) 2001-10-09 2004-08-10 Tissue Adhesive Technologies, Inc. Light energized tissue adhesive conformal patch
US20030139737A1 (en) 2002-01-24 2003-07-24 J.T. Lin Method and apparatus for treatment of presbyopia by lens relaxation and anterior shift
US6997553B2 (en) 2002-08-07 2006-02-14 Global-Ok Vision, Inc. Contact lens for reshaping the altered corneas of post refractive surgery, previous ortho-K of keratoconus
KR20050042819A (ko) * 2002-09-13 2005-05-10 오큘라 사이언시즈, 인크. 시력 개선 장치 및 방법
GB0229577D0 (en) 2002-12-19 2003-01-22 Bausch & Lomb Contact lens manufacture
WO2005022242A1 (en) 2003-08-27 2005-03-10 The Institute For Eye Research Soft lens orthokeratology
RU2231814C1 (ru) 2003-10-29 2004-06-27 Егорова Галина Борисовна Универсальный пробный набор жестких газопроницаемых контактных линз для коррекции кератоконуса
MXPA03011987A (es) 2003-12-19 2005-06-23 Osio Sancho Alberto Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal.
US20050256065A1 (en) 2004-01-26 2005-11-17 Permasight Method for stabilizing changes in corneal curvature in an eye by administering compositions containing stabilizing ophthalmic agents
MXPA05000125A (es) 2004-12-17 2006-06-19 Sancho Alberto Osio Metodo para el tratamiento de condiciones oftalmicas.
US7559649B2 (en) 2005-01-12 2009-07-14 Dakota Sciences, LLC Corneal-scleral orthokeratology contact lens
JP2007195818A (ja) 2006-01-27 2007-08-09 Akihiro Oguri オルソケラトロジー用コンタクトレンズ
US20080024717A1 (en) 2006-07-28 2008-01-31 Stanton Kim Contact lens used in orthokeratology
JP2008112120A (ja) 2006-10-30 2008-05-15 Eyemed Co Ltd 多面フィッティングオルソｋレンズ
JP4992051B2 (ja) 2008-06-09 2012-08-08 株式会社アイメディ商事 角膜矯正療法用処方コンタクトレンズの選定装置
AU2011223499B2 (en) 2010-03-03 2015-08-27 Brien Holden Vision Institute Corneal remodelling contact lenses and methods of treating refractive error using corneal remodelling
US8366272B1 (en) 2011-08-19 2013-02-05 Contact Lens Precision Laboratories Limited Fitting contact lenses for irregular corneas
ES2994608T3 (en) 2012-08-10 2025-01-27 Osio Corp D/B/A Yolia Health Contact lens use in the treatment of an ophthalmologic condition

Also Published As

Publication number Publication date
US9566317B2 (en) 2017-02-14
US20150216952A1 (en) 2015-08-06
WO2005062818A3 (en) 2005-10-13
CR8453A (es) 2006-12-07
ECSP066657A (es) 2006-11-24
US20070122450A1 (en) 2007-05-31
WO2005062818A2 (en) 2005-07-14
AU2004308326A1 (en) 2005-07-14
KR20070012329A (ko) 2007-01-25
US8679521B2 (en) 2014-03-25
US8475831B2 (en) 2013-07-02
US20140271597A1 (en) 2014-09-18
ZA200605950B (en) 2007-12-27
CN1901882A (zh) 2007-01-24
RU2006126077A (ru) 2008-01-27
JP5715875B2 (ja) 2015-05-13
BRPI0417785A (pt) 2007-03-20
CN100591354C (zh) 2010-02-24
WO2005062818A8 (en) 2006-10-05
EP1706094B1 (de) 2018-07-18
MXPA03011987A (es) 2005-06-23
HK1099232A1 (zh) 2007-08-10
IL176397A0 (en) 2006-10-05
EP1706094A2 (de) 2006-10-04
US9241980B2 (en) 2016-01-26
EP1706094A4 (de) 2012-03-28
JP2015180354A (ja) 2015-10-15
EG24420A (en) 2009-05-25
IL176397A (en) 2012-03-29
US20160367647A1 (en) 2016-12-22
JP6084661B2 (ja) 2017-02-22
US9931382B2 (en) 2018-04-03
JP2007514760A (ja) 2007-06-07
WO2005062818B1 (en) 2005-11-24
JP2011153153A (ja) 2011-08-11
JP2017057219A (ja) 2017-03-23
AU2004308326B2 (en) 2011-02-10
US20170266267A1 (en) 2017-09-21
CA2549333A1 (en) 2005-07-14
US8877228B2 (en) 2014-11-04
US20140017220A1 (en) 2014-01-16
JP6397876B2 (ja) 2018-09-26

Similar Documents

Publication Publication Date Title
US9931382B2 (en) Treatment of ophthalmic conditions
JP2007514760A6 (ja) 眼科的状態の処置
US9086580B2 (en) Contact lens use in the treatment of an ophthalmologic condition
Montalt et al. Visual quality with corneo-scleral contact lenses for keratoconus management
JP6696952B2 (ja) 眼科的状態の処置
MXPA05000125A (es) Metodo para el tratamiento de condiciones oftalmicas.
HK1099232B (en) Treatment of ophthalmic conditions
JP2013078659A (ja) 眼科的状態の処置
Ribeiro A Retrospective Analysis of Dry Eye Interventions During the First Postoperative Year of Patients Undergoing Lasik Versus Prk
Coleman et al. Secretary for quality of care
Sanchez et al. The effects of night wear orthokeratology lenses on central cornela thickness
McLeod et al. Prepared by the American Academy of Ophthalmology Refractive Management/Intervention Panel Refractive Management/Intervention Panel Members
Lasik et al. Refractive Surgery
Kanellopoulos Sequential versus simultaneous CXL and topography-guided PRK

Legal Events

Date Code Title Description
EEER Examination request
H11 Ip right ceased following rejected request for revival

Free format text: ST27 STATUS EVENT CODE: T-6-6-H10-H11-H101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TIME LIMIT FOR REVERSAL EXPIRED

Effective date: 20250618

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-H100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE AND LATE FEE NOT PAID BY DEADLINE OF NOTICE

Effective date: 20251105